Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 1;218(8):374-375.
doi: 10.5694/mja2.51900. Epub 2023 Mar 23.

The Queensland IMplementation of PRecision Oncology in brEast cancer (Q-IMPROvE) pilot study

Amy E McCart Reed  1 , Georgina Hollway  2   3 ; Q-IMPROvE study group; Sunil Lakhani  1   4
Affiliations

The Queensland IMplementation of PRecision Oncology in brEast cancer (Q-IMPROvE) pilot study

Amy E McCart Reed et al. Med J Aust. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Med J Aust. 2023 Jun 19;218(11):544. doi: 10.5694/mja2.51975. Epub 2023 May 18. Med J Aust. 2023. PMID: 37201924 No abstract available.
No abstract available

Keywords: Breast neoplasms; Cancer; Cancer genes; Genetic testing; Molecular medicine; Pathology, molecular.

PubMed Disclaimer

References

    1. Vidgen ME, Williamson D, Cutler K, et al. Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system. NPJ Genom Med 2021; 6: 71.
    1. Gennari A, Andre F, Barrios CH, et al; ESMO Guidelines Committee. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer. Ann Oncol 2021; 32: 1475-1495.
    1. André F, Ciruelos EM, Juric D, et al. Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1. Ann Oncol 2021; 32: 208-217.
    1. Davies H, Glodzik D, Morganella S, et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat Med 2017; 23: 517-525.
    1. Telli ML, Timms KM, Reid J, et al., Homologous recombination deficiency score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer. Clin Cancer Res 2016; 22: 3764-3773.

Publication types

LinkOut - more resources